Updated: Jul 31
The topic of Alzheimer's disease (AD) is near and dear to my heart and a harrowing one because my father developed dementia. It took his life after a long battle. A sense of fear bubbles to the surface once in a while as I wonder if the same fate awaits me.
According to recent estimates, AD may be ranked as the third leading cause of death, just behind heart disease and cancer . We now understand that AD is a brain disorder and the most common cause of dementia. AD was named after Dr. Alois Alzheimer in 1906, as she observed changes in the brain tissue of a woman who died of an unusual mental illness, exhibiting symptoms of memory loss, language problems, and unpredictable behavior. In this patient's brain tissue, she identified abnormal clumps (amyloid plaques) and tangled bundles of fibers (neurofibrillary, tangles, or tau). These plaques and tangles are considered the main characteristics of AD. Another characteristic is the loss of connections between neurons, leading to challenges in transmitting signals within different parts of the brain as well as from the brain to the rest of the body .
As scientists continue to unravel the various aspects of AD, it’s now understood that changes in the brain may begin a decade or more before symptoms initially manifest. The damage initially occurs in the hippocampus and entorhinal cortex - parts of the brain that are essential in forming memories. As additional neurons die, more areas in the brain are also affected. By the final stage, cell damage is widespread, resulting in significant brain shrinkage.
In recent years, scientists have made tremendous progress but still haven’t completely understood the pathophysiology and etiology of AD. It’s complex! Causes may include a combination of aging, inflammation, insulin resistance, mitochondrial and metabolic dysfunction, genetics, and epigenetic factors. These factors that may increase or reduce the risk of developing AD vary from person to person.
Genetics – Alone, does it determine fate?
There may be multiple genes involved as risk factors for AD. In particular, one of the APOE genetic variants - APOE ε4 - is infamous and draws special attention. (Thank God, I found out I don't have this variant!) However, it’s crucial to remember that carrying the APOE ε4 does not necessarily mean that a person will develop the disease, and individuals with no APOE ε4 may still develop AD.
Epigenetic Factors – Do they play a role?
Research suggests many factors beyond genetics may play a role in AD development. There has been much discussion on the connections between cognitive decline and cardiovascular disease, Type 2 diabetes, and obesity. Moreover, nutrition, physical activity, social engagement, and mental stimulation are all hot topics that are considered more promising modalities for reducing the risk of cognitive decline.
Diet may influence cognitive aging via several inflammatory pathways . Diet is crucial in delivering antioxidants and anti-inflammatory factors, balancing gut microbiomes, and addressing digestive disorders linked to food sensitivities that may alleviate inflammation and slow AD progression . Several dietary approaches have been studied for preventing or managing AD, including the Ketogenic diet, anti-inflammatory diet, Mediterranean diet, DASH diet, Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet, and intermittent fasting . So, the big question is: which diet to choose? Here is how to prioritize: Don’t worry about the name of the diet but focus instead on creating a personalized approach by sticking with the principles focused on taming systemic inflammation, reducing oxidative stress, and optimizing mitochondrial function:
Replace processed foods with a whole-food-based diet comprised primarily of plant-based foods with a heavy intake of vegetables and fruits.
Go low on grains: Many people have non-Celiac gluten sensitivity, promoting a chronic inflammatory state and contributing to brain neuroinflammation and AD pathogenesis . Other non-gluten grains contain antinutrients such as lectin and phytates, which can also contribute to inflammation. However, a small pseudo-grain intake (quinoa, amaranth, and buckwheat) is considered benign.
Reduce glycemic load: Recent studies have shown that a high-glycemic diet is associated with a greater cerebral amyloid burden. Poorly controlled blood sugar may increase the risk of developing AD. Some even call AD “diabetes of the brain” or “Type 3 diabetes” [6,7]. Consuming low-glycemic foods and meals with low glycemic loads may lower the risk of AD or slow AD progression. Also, foods rich in omega-3 polyunsaturated fats should be consumed regularly to improve insulin sensitivity.
Special foods for supporting mitochondrial function: That mitochondrial dysfunction promotes AD is a well‐accepted finding. There is evidence to support the notion that abnormal mitochondrial function may trigger neurodegeneration . The Mito Food Plan can be incorporated as an addition. It’s described as the anti-inflammatory, low-glycemic, gluten-free, low-grain, high-quality fats approach (many things listed above). It also emphasizes supporting mitochondria function to improve energy production using therapeutic foods such as DHA from omega-3 polyunsaturated fat and coconut MCT oil.
From the perspective of a healthy diet, cooking methods should also be considered. Improper cooking habits can contribute to the loss of nutrients and the formation of toxins such as advanced glycation end products (AGEs). Studies have shown that the accumulation of AGEs in the body can cause excess oxidative stress and exacerbate neurodegenerative and other chronic diseases. Generally, steaming is an excellent way to cook vegetables, and low heat and wet cooking style is recommended for preparing animal meat.
A COUPLE OF SUPPLEMENTAL THERAPIES
There is an extensive list of nutritional supplements that can be beneficial in preventing and managing AD. It should be personalized depending on a person’s diet and blood chemistry. Here, I picked two that are most fundamental but essential and almost impossible to get enough of from foods:
Curcumin: Curcumin has been extensively studied and shown to possess neuroprotection biological properties due to its anti-inflammatory and antioxidant effects. I recommend choosing a product with a concentrated source of curcuminoids (standardized to 95%), prepared in phosphatidylcholine and MCT oil, and combined with black pepper extract for enhanced absorption. The dosage can be 400 – 1000 mg daily.
Vitamin D3: Studies have shown significant associations between vitamin D deficiency and both dementia and AD. I recommend regular blood testing to monitor serum 25(OH)D at least twice a year, intending to get its level in the range of 60-100 ng/ml. When it comes to supplementation, it’s ideal to choose an oil-based product in either MCT oil or olive oil, combined with vitamin K2 MK-7 for improved absorption. Dosage can be in the range of 2,000-10,000 IU depending on an individual’s serum 25(OH)D level.
No matter how challenging it feels, always keep the hope deep in your soul because that’s what we live for and can keep us going. In the meantime, live one day at a time.
Jenny Noland, MS, CNS, CNGS, CKNS, LDN, MBA
Functional Nutritionist in Eugene, Oregon
Board-Certified Nutrition Specialist
Board-Certified Nutritional Genomics Specialist
Board-Certified Ketogenic Nutrition Specialist
Certified Oncology Nutrition Specialist
Personalized Nutrition Therapy for Metabolic Dysfunction and Cancer Care
To learn more about our services, please visit the Service Offerings page.
To book a discovery call, please visit the Book Consult page or call 541-255-5047.
FastStats - Leading Causes of Death. Accessed August 9, 2021. https://www.cdc.gov/nchs/fastats/leading-causes-of-death.htm
Alzheimer’s disease: Overview - InformedHealth.org - NCBI Bookshelf. Accessed August 15, 2021. https://www.ncbi.nlm.nih.gov/books/NBK279360/
McGrattan AM, McGuinness B, McKinley MC, et al. Diet and Inflammation in Cognitive Ageing and Alzheimer’s Disease. Curr Nutr Reports 2019 82. 2019;8(2):53-65. doi:10.1007/S13668-019-0271-4
Vasefi M, Hudson M, Ghaboolian-Zare E. Diet Associated with Inflammation and Alzheimer’s Disease. J Alzheimer’s Dis Reports. 2019;3(1):299. doi:10.3233/ADR-19015
Cremonini AL, Caffa I, Cea M, Nencioni A, Odetti P, Monacelli F. Nutrients in the Prevention of Alzheimer’s Disease. Oxid Med Cell Longev. 2019;2019. doi:10.1155/2019/9874159
Taylor MK, Sullivan DK, Swerdlow RH, et al. A high-glycemic diet is associated with cerebral amyloid burden in cognitively normal older adults. Am J Clin Nutr. 2017;106(6):1463. doi:10.3945/AJCN.117.162263
Nguyen TT, Ta QTH, Nguyen TKO, Nguyen TTD, Giau V Van. Type 3 Diabetes and Its Role Implications in Alzheimer’s Disease. Int J Mol Sci. 2020;21(9). doi:10.3390/IJMS21093165
Ortiz JMP, Swerdlow RH. Mitochondrial dysfunction in Alzheimer’s disease: Role in pathogenesis and novel therapeutic opportunities. Br J Pharmacol. 2019;176(18):3489. doi:10.1111/BPH.14585
Abate G, Marziano M, Rungratanawanich W, Memo M, Uberti D. Nutrition and AGE-ing: Focusing on Alzheimer’s Disease. Oxid Med Cell Longev. 2017;2017. doi:10.1155/2017/7039816
Gagliardi S, Franco V, Sorrentino S, et al. Curcumin and Novel Synthetic Analogs in Cell-Based Studies of Alzheimer’s Disease. Front Pharmacol. 2018;0:1404. doi:10.3389/FPHAR.2018.01404